Abstract
Lornoxicam is available in the market as a solid dosage form, particularly tablets. Liquid chromatography has been the recommended assay procedure for lornoxicam in various pharmacopeias. While going through the literature, it was observed that for the analysis of lornoxicam, no FTIR based method was found. The present study involves the development of a novel, rapid, superior, labor-free, non-destructive, and economic FTIR-based analytical technique for the analysis of lornoxicam in both bulk and tablet formulations. International Council validated the method for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines Q2A and Q2B in accordance with the United States Food and Drug Administration (USFDA) guidance and by United States Pharmacopoeia (USP). FTIR based method is extremely precise, quite linear, very accurate, and has adequate ruggedness. The developed method can be of potential use in the routine quantitative drug analysis of lornoxicam in the pharmaceutical industry for quality control purposes.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
